Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Patent services for leading AI innovator OpenAI Patent services for leading AI innovator OpenAI
Experience
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Experience
Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement
Eisai Co., Ltd.
Experience
TCL Communication Technology Holdings Ltd. v. Telefonaktiebolaget LM Ericsson TCL Communication Technology Holdings Ltd. v. Telefonaktiebolaget LM Ericsson
18-1363, -1380, -1382, -1732, Fed. Cir., Judges Newman, Chen, Hughes
TCL Communication Technology Holdings Ltd. et al.
Experience
Prosecuting patents for startup Hutchison Medipharma Prosecuting patents for startup Hutchison Medipharma
Hutchison Medipharma
Experience
Startup sold to major drug company based on strength of patents Startup sold to major drug company based on strength of patents
Agouron Pharmaceuticals, Inc.
Experience
Finnegan tees up valuable patents for Principia Biopharma, leading to major acquisition deal Finnegan tees up valuable patents for Principia Biopharma, leading to major acquisition deal
Principia Biopharma
Experience
Helped a global chemical company conduct due diligence when acquiring IP rights in nanotechnology Helped a global chemical company conduct due diligence when acquiring IP rights in nanotechnology
Experience
Utility and design patent applications for brain machine interface company Utility and design patent applications for brain machine interface company
BrainCo
Experience
IP strategy for parts businesses threatened by 3D printing IP strategy for parts businesses threatened by 3D printing
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.